research

Aligning your goals with deeply held values produces better results—in your career and life.

Pharmaceutical giant Pfizer will likely know by the end of next month if its coronavirus vaccine is effective, CEO Albert Bourla said. There’s a “more than 60 percent” chance that the drugmaker’s clinical research will produce results by the end of October showing whether or not the shot works, Bourla said in a Sunday TV …

AstraZeneca’s coronavirus vaccine could still be ready this year even though it had to halt a key clinical study after a participant got sick, CEO Pascal Soriot said Thursday. The British pharmaceutical firm should know by the end of 2020 whether the vaccine protects patients from the virus if it’s able to resume the study …

Facebook users will be paid up to $120 to shut down their accounts as part of an experiment on how the platform affects elections. The social-media giant is reportedly recruiting users willing to give up Facebook and Instagram for one or six weeks in late September for a study of how the apps influence political …

Johnson & Johnson kicked off human trials of its experimental COVID-19 vaccine Thursday, after the shots already proved successful in protecting monkeys, the drugmaker announced. Company honchos pointed to a new study which found that five out of six primates who got the single-dose shot were protected from infection when exposed to the coronavirus, as …

British drugmaker Synairgen says it has developed a new coronavirus inhaler treatment that helps prevent hospitalized patients from getting seriously ill. The company announced results Monday from a small clinical trial of its drug known as SNG001 that it called a potential “major breakthrough” in the fight against the bug, even though the study reportedly …

The FBI and the Department of Homeland Security’s cyber division warned on Wednesday that hackers backed by the Chinese government may be attempting to steal the work of researchers dealing with the response to the coronavirus outbreak. Both the FBI and the US Cybersecurity and Infrastructure Security Agency said that health care and pharmaceutical researchers …

An antiviral drug seen as a potentially promising treatment for the new coronavirus reportedly failed to help patients in a Chinese study. The clinical trial found that remdesivir — the Gilead Sciences medicine developed to treat Ebola — didn’t help COVID-19 patients recover faster or prevent them from dying, according to news reports. Results from …